Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Best of the Blogs, Biotech: The End of Florida's Pill Mills? Let's Hope.


Plus, the surprising funding source behind university agricultural research.

This column highlights the most interesting and useful biotech news from around the Web every Thursday.
Philly Pharma
"Cardinal Health (CAH), one of the big three pharmaceutical wholesalers, reached an agreement with the U.S. Drug Enforcement Administration, under which Cardinal Health will not ship controlled substances from its Lakeland, Fla., distribution center for two years. Misuse of prescription painkillers have passed cocaine and heroin as drugs that kill people in America, according to the Centers for Disease Control and Prevention. So-called pill mills in Florida have been one hotspot in that national problem." (Also read Health-Care Sector's Paltry Insurance Against Risk of Change.)

Food Whistle Blower
"Just this week, the St. Louis Post-Dispatch reported that everyone's favorite biotech behemoth, Monsanto (MON), has allotted $250,000 to an agricultural communications chair position at the University of Illinois, which will run a new degree program between the College of Media and College of Agriculture, Consumer and Environmental Sciences." (For related content, see You Decide: 11 Game-Changing Copyright Cases.)
Fierce Biotech
Link: Kythera Files $86M IPO to Support Fat-Busting Drug
"After raising $108 million in venture cash, LA-based Kythera Biopharmaceuticals has filed for an IPO designed to contribute about $86 million. The IPO's success will hinge on the company's ability to generate some investor excitement over ATX-101, a late-stage fat-busting therapy intended to cure people of the double chin."
National Defense Magazine
Link: GOP Amendments Could Derail Military Biofuels Plan
"Proposed amendments to the fiscal year 2013 National Defense Authorization Act could dash the Pentagon's hopes of a green future. Last week, the House Armed Services Committee voted to prohibit the Defense Department from buying pricey alternative fuels and to repeal part of the Energy Independence and Security Act of 2007 that has been the catalyst for efforts to wean the country off petroleum." (For related content, see Renewable Energy Crop Production Set to Soar in US.)
Financial Times: FT Alphaville
Link: Greece: When the Drugs Run Out
"Beneath the political stasis - another sign of a sharp turn for the worse in Greece's liquidity crisis. The country's pharmacies are owed €500m by the state-backed healthcare insurer, according to reports. From next week patients will have to stump up the cash for their medicines upfront, and then claim a reimbursement from the National Organization for Healthcare Provision."

Twitter: @wont_tweet_ever
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Featured Videos